Mr Dan Bernal
Lecturer in Clinical Pharmacokinetics
|Contact Campus||Sandy Bay Campus|
|Telephone||+61 3 6226 1078|
|Fax||+61 3 6226 7627|
Mr Bernal began his career as a clinical pharmacist at the Launceston General Hospital, where he worked with several medical units, including cardiology, oncology and the stroke unit. In 2011, he commenced study toward a PhD in pharmacy practice, specifically looking at the impact of home medicines reviews as a follow up service for heart attack survivors. While finishing this project, he is now lecturing in Clinical Pharmacokinetics to 3rd and 4th year pharmacy students.
Mr Bernal's specific interests are in medication adherence and preventive cardiovascular medicine, as well as Clinical Pharmacokinetics, looking specifically at how the body handles various medicines and how this information can be used to improve patient safety and clinical outcomes. He teaches Clinical Pharmacokinetics 3 (CSA311), Clinical Pharmacokinetics (CSA312), Clinical Pharmacokinetics (CSA314), & Clinical Pharmacokinetics 4 (CSA414). He also supervises 3rd and 4th year pharmacy hospital rounds, helping students gain exposure to clinical pharmacy in a practice-based learning environment.
Mr Bernal is currently focused on completing a randomised controlled trial of Home Medicines Reviews following Acute Coronary Syndromes. Essentially this has looked at the impact of a pharmacist home-visit as a follow-up service for heart attack survivors. This research aims to improve adherence to guideline-based medications that can have long-term benefits when taken correctly following a heart attack. This research will also provide valuable insight into the heart-health habits of patients following a heart attack, including their attitudes towards medication, smoking cessation, cardiac rehabilitation, and an assessment of their quality of life.
See video at: https://www.youtube.com/watch?v=IWJKvu4BwRE
Research Expertise and Specific Skills
- Design and conduct of randomised controlled trials
- Survey development and design theory
- Medication adherence management
- Strategies to improve the secondary prevention of coronary heart disease